Addressing key challenges in the modern sales sector requires a fundamental shift in training strategies.
Marina Hickson
Chief executive officer
Vivanti
The pharmaceutical industry is at a critical juncture: sales performance is lagging, demanding immediate and transformative action. PwC's "Next in Pharma 2025" report1 highlights a troubling trend—pharma companies have returned just 7.6% to shareholders from 2018 to 2024, compared to the S&P 500's 15%. This widening gap highlights the need for a vastly different approach to sales as competition intensifies and healthcare models evolve.
Sales challenges were also at the forefront of Salesforce’s "State of Sales Report 20242" which surveyed over 5,500 sales professionals and identified that the number one top priority for sales leaders is improving sales enablement and training.
The statistics are compelling:
These inefficiencies are creating a significant skills gap, prolonging the onboarding phase, and weakening the connection between sales and marketing teams. Addressing these key challenges, however, requires a fundamental shift in training strategies and AI solutions offer a powerful antidote.
Sales organisations must confront several pressing issues:
These issues are not insurmountable. The solution lies in rethinking how training is delivered—moving away from traditional, one-size-fits-all approaches to dynamic, tailored learning experiences.
A common challenge in pharma sales is the misalignment between sales and marketing teams. Without a cohesive strategy, messaging becomes inconsistent, and reps lack the necessary knowledge to engage effectively with healthcare professionals. A connected learning ecosystem can address this by allowing marketing teams, trainers, and managers to provide real-time, engaging content that sales reps can absorb efficiently through immersive experiences and interactive learning tools.
Reducing the 11.2-month ramp time for new executives is crucial. New reps need practical, hands-on learning experiences that allow them to develop their skills in a risk-free environment. AI-powered training tools that simulate real-world healthcare provider (HCP) interactions can accelerate skill development, making onboarding far quicker and more effective. These systems also provide real-time feedback, allowing reps to refine their approach immediately.
Additionally, sales managers—who are already stretched thin—need tools that provide detailed analytics on rep performance. AI-driven coaching solutions can assess how reps interact with HCPs, identify strengths and weaknesses, and offer actionable feedback. This ensures managers can focus on targeted coaching rather than broad, generic feedback, maximizing their limited time.
Beyond onboarding, reps need ongoing support to stay ahead. AI-driven virtual mentors can offer personalized training content based on each rep’s career stage and past performance. These systems provide instant access to product details, compliance information, and strategy insights, ensuring reps are always equipped with the knowledge they need, when they need it. This proactive approach enhances confidence, efficiency, and overall productivity.
For pharmaceutical companies to remain competitive, they must prioritize structured, data-driven sales enablement. Key outcomes of effective training solutions include:
The latest industry research makes one thing clear: without meaningful investment in sales training and enablement, pharmaceutical companies risk falling behind. High-performing reps do not just emerge—they are developed through consistent, personalized training and strong support systems. AI-powered solutions now offer seamless collaboration between teams, ongoing mentorship, and real-time performance analytics, transforming the way sales organizations operate.
For sales leaders, the message is simple: the time for change is now.
Vivanti is a digital marketing innovator in the pharmaceutical sector. AVA AI Trainer is part of Vivanti’s COSMART suite, a collection of AI-driven tools designed to drive commercial excellence.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.